Showing results (21-30 of 30) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Cancer Prevention Research (Philadelphia, Pa.)|March 4, 2016
Inflammation-Related IL1β/IL1R Signaling Promotes the Development of Asbestos-Induced Malignant MesotheliomaYuwaraj Kadariya, Craig W Menges, Jacqueline Talarchek, et al.BMC Cancer|May 9, 2015
Mesothelioma patient derived tumor xenografts with defined BAP1 mutations that mimic the molecular characteristics of human malignant mesotheliomaNeetu Kalra, Jingli Zhang, Anish Thomas, et al.Molecular Cancer Research : MCR|January 27, 2022
Inactivation of p21-Activated Kinase 2 (Pak2) Inhibits the Development of Nf2-Deficient Tumors by Restricting Downstream Hedgehog and Wnt SignalingEleonora Sementino, Yuwaraj Kadariya, Mitchell Cheung, et al.Cancer Research|June 2, 2019
Inactivation of <i>Bap1</i> Cooperates with Losses of <i>Nf2</i> and <i>Cdkn2a</i> to Drive the Development of Pleural Malignant Mesothelioma in Conditional Mouse ModelsAnna-Mariya Kukuyan, Eleonora Sementino, Yuwaraj Kadariya, et al.Cancer Research|June 15, 2014
Germline mutation of Bap1 accelerates development of asbestos-induced malignant mesotheliomaJinfei Xu, Yuwaraj Kadariya, Mitchell Cheung, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2020
Somatic Epigenetic Silencing of <i>RIPK3</i> Inactivates Necroptosis and Contributes to Chemoresistance in Malignant MesotheliomaYinfei Tan, Eleonora Sementino, Mitchell Cheung, et al.Nature Genetics|August 30, 2011
Germline BAP1 mutations predispose to malignant mesotheliomaJoseph R Testa, Mitchell Cheung, Jianming Pei, et al.Molecular Cancer Research : MCR|March 18, 2021
Kinetic Characterization of ASXL1/2-Mediated Allosteric Regulation of the BAP1 DeubiquitinaseHongzhuang Peng, Joel Cassel, Daniel S McCracken, et al.Oncotarget|September 30, 2016
Haploinsufficiency in tumor predisposition syndromes: altered genomic transcription in morphologically normal cells heterozygous for VHL or TSC mutationSuraj Peri, Elena Caretti, Rossella Tricarico, et al.Journal of the National Cancer Institute|December 6, 2018
Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families WorldwideSebastian Walpole, Antonia L Pritchard, Colleen M Cebulla, et al.Pageof 3